Daily startup and blockchain data-wiki with interviews, Q&A's & discussions about funding rounds & investors.

RaisedToday moderators manually update and approve wiki edits - check back every 1-2h for approved submissions.

Contributed by laura998

Sanofi

1 Disclosed Funding Rounds $310,000,000

14 Participating Investments $430,564,039


Therapeutics, Marketing, Health Care, Medical, Manufacturing

Sanofi is engaged in the research, development, manufacturing, and marketing of innovative therapeutic solutions.

Paris, Ile-de-France, France, Europe (FR)

Organizations in Paris in Therapeutics,
Organizations in Paris in Marketing,
Organizations in Paris in Health Care,
Organizations in Paris in Medical,
Organizations in Paris in Manufacturing,
Organizations in Ile-de-France in Therapeutics,
Organizations in Ile-de-France in Marketing,
Organizations in Ile-de-France in Health Care,
Organizations in Ile-de-France in Medical,
Organizations in Ile-de-France in Manufacturing,
Organizations in France in Therapeutics,
Organizations in France in Marketing,
Organizations in France in Health Care,
Organizations in France in Medical,
Organizations in France in Manufacturing,
Organizations in Europe in Therapeutics,
Organizations in Europe in Marketing,
Organizations in Europe in Health Care,
Organizations in Europe in Medical,
Organizations in Europe in Manufacturing

Investors in Paris in Therapeutics,
Investors in Paris in Marketing,
Investors in Paris in Health Care,
Investors in Paris in Medical,
Investors in Paris in Manufacturing,
Investors in Ile-de-France in Therapeutics,
Investors in Ile-de-France in Marketing,
Investors in Ile-de-France in Health Care,
Investors in Ile-de-France in Medical,
Investors in Ile-de-France in Manufacturing,
Investors in France in Therapeutics,
Investors in France in Marketing,
Investors in France in Health Care,
Investors in France in Medical,
Investors in France in Manufacturing,
Investors in Europe in Therapeutics,
Investors in Europe in Marketing,
Investors in Europe in Health Care,
Investors in Europe in Medical,
Investors in Europe in Manufacturing

European Union (EU) (0 Investors) (0 Startups)

Founded date 08, 2004

Founders Jean-René Sautier, Jean-François Dehecq

Operating Status Active

Funding Stage IPO

Last Funding Type Post-IPO Equity

Company Type For Profit


Facebook Link

Twitter Link

LinkedIN Link

Wikipedia Link

Sanofi is a healthcare company engaged in the research, development, manufacturing, and marketing of innovative therapeutic solutions. It covers areas such as diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health and the new G enzyme. Its products includes prescriptions and over-the-counter drugs for thrombosis, cardiovascular disease, diabetes, central nervous system disorders, oncology and internal medicine, vaccines and other medical products. The two young groups Sanofi and Synthélabo merged in May 1999 to create a major new pharmaceutical player. Sanofi dates back to 1973 and Synthélabo to 1970. In December 1999, Rhône-Poulenc and Hoechst Marion Roussel formalized their merger with the creation of the Franco-German group Aventis, one of the world’s largest pharmaceutical companies. In August 2004, Sanofi-Synthelabo acquired Aventis. The takeover was finalized on December 31 of that year, giving birth to sanofi-aventis. On May 6, 2011, sanofi-aventis simplified its name to Sanofi. Sanofi  operates in over 100 countries throughout the world.

Date Round Raised Lead
December, 02, 2014 Post-IPO Equity $310,000,000 Evotec

Sanofi Participated In the Following Investment Rounds (14)

Organization Name Lead? Round Partners Participating Raise Date
Novadiscovery Yes Series A ------- $3,022,061 February, 16, 2021
Icosavax No Series A ------- $51,000,000 October, 03, 2019
Veralox Therapeutics Yes Seed ------- $5,400,000 September, 05, 2019
Aetion No Series B ------- $27,000,000 February, 05, 2019
BioNTech Yes Private Equity ------- $91,164,039 January, 04, 2019
Enable Injections Yes Series B ------- $50,000,000 October, 25, 2018
JHL Biotech Yes Post-IPO Equity ------- Undisclosed October, 02, 2018
Fulcrum Therapeutics No Series B ------- $80,000,000 September, 05, 2018
Thermalin Yes Series A ------- $17,500,000 September, 28, 2017
JHL Biotech No Private Equity ------- $80,000,000 December, 05, 2016
Onduo No Seed ------- Undisclosed September, 12, 2016
Portal Instruments Yes Series A ------- $11,000,000 October, 15, 2014
MyoKardia No Venture - Series Unknown ------- $10,000,000 August, 22, 2014
Esperance Pharmaceuticals Yes Series B ------- $7,500,000 June, 01, 2011

Sanofi Investors (1)

Investor Lead? Round Participating Raise Date Partners
Evotec Yes Post-IPO Equity $310,000,000 December, 02, 2014 -------